Abstract
Background
While the typical features of large cholangiocarcinomas have been described extensively and are known to radiologists, atypical cholangiocarcinomas are not as well known and radiologists should be more aware of their features. Due to the increasing numbers of cross-sectional imaging studies performed for various reasons, cholangiocarcinomas may be more frequently detected incidentally when small, before they become symptomatic, and might be mistaken for other liver lesions. We studied the appearance of misdiagnosed cholangiocarcinomas.
Materials and methods
This is a HIPAA-compliant, IRB-approved retrospective study. Our institutional database and teaching files were searched for cases of cholangiocarcinomas diagnosed between 2004 and 2014 that were initially misdiagnosed or considered indeterminate lesions on MRI or CT. Clinical data and radiological findings were collected. History of malignancy and risk factors for cholangiocarcinoma were recorded. The initial reported diagnosis and time to the correct diagnosis were noted, and the lesions were evaluated for size, enhancement, T1/T2 signal, diffusion restriction, ADC value, capsular retraction, biliary dilatation and the presence of satellite nodules.
Results
Nine examples of cholangiocarcinoma that met our inclusion criteria were identified: seven men and two women. All were small, with a mean size of 2.2 cm upon initial diagnosis. All showed a hypervascular pattern of enhancement without washout. Imaging features that are described in the literature as typical for cholangiocarcinomas, such as capsular retraction, satellite nodules, and peripheral biliary dilatation, were not seen.
Conclusion
Cholangiocarcinomas can be misdiagnosed when they are small and hypervascular. This atypical hypervascular appearance is rare, and may mimic benign liver lesions and other malignant lesions, especially when small. Awareness of the confounding imaging features of these tumors should lead to a more meticulous evaluation of small hypervascular lesions, and may minimize the risk of misdiagnosing early-stage cholangiocarcinomas.
Similar content being viewed by others
References
Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873–875. doi:10.1093/jnci/djj234
Charbel H, Al-Kawas FH (2011) Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13(2):182–187. doi:10.1007/s11894-011-0178-8
Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215–1229. doi:10.1053/j.gastro.2013.10.013
Burak K, Angulo P, Pasha TM, et al. (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99(3):523–526. doi:10.1111/j.1572-0241.2004.04067.x
Tyson GL, El-Serag HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54(1):173–184. doi:10.1002/hep.24351
Chung YE, Kim MJ, Park YN, et al. (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29(3):683–700. doi:10.1148/rg.293085729
Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 158(1):77–79
Vilgrain V, Van Beers BE, Flejou JF (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65
Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol: JACR 7(10):754–773. doi:10.1016/j.jacr.2010.06.013
Ehrl D, Rothaug K, Herzog P, Hofer B, Rau HG (2012) “Incidentaloma” of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012:891787. doi:10.1155/2012/891787
Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210(1):71–74. doi:10.1148/radiology.210.1.r99ja0371
Khalil HI, Patterson SA, Panicek DM (2005) Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235(3):872–878. doi:10.1148/radiol.2353041099
Koea JB (2013) Hepatic incidentaloma: the rule of tens. HPB: Off J Int Hepato Pancreato Biliary Assoc 15(5):379–383. doi:10.1111/j.1477-2574.2012.00595.x
Della Corte C, Colombo M (2012) Surveillance for hepatocellular carcinoma. Semin Oncol 39(4):384–398. doi:10.1053/j.seminoncol.2012.05.002
Xu J, Igarashi S, Sasaki M, et al. (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int: Off J Int Assoc Study Liver 32(7):1156–1164. doi:10.1111/j.1478-3231.2012.02783.x
Parente DB, Perez RM, Eiras-Araujo A, et al. (2012) MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma. Radiographics 32(3):767–787. doi:10.1148/rg.323115131
Vallin M, Sturm N, Lamblin G, et al. (2013) Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants. Clin Transplant 27(3):403–409. doi:10.1111/ctr.12108
Dhanasekaran R, Hemming AW, Zendejas I, et al. (2013) Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 29(4):1259–1267. doi:10.3892/or.2013.2290
Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38(4):793–801. doi:10.1007/s00261-012-9943-x
Takakura K, Kajihara M, Iwasaki T, et al. (2013) Unusual images of mass-forming intrahepatic cholangiocarcinoma. Case Rep Gastroenterol 7(3):414–419. doi:10.1159/000352015
D’Onofrio M, Vecchiato F, Cantisani V, et al. (2008) Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 113(1):76–86. doi:10.1007/s11547-008-0225-1
Keogan MT, Seabourn JT, Paulson EK, et al. (1997) Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging. AJR Am J Roentgenol 169(6):1493–1499. doi:10.2214/ajr.169.6.9393152
Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176(6):1499–1507. doi:10.2214/ajr.176.6.1761499
Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264(3):751–760. doi:10.1148/radiol.12112308
Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ (2013) Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma. J Comput Assist Tomogr 37(6):872–881. doi:10.1097/RCT.0b013e31829d44c1
Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709. doi:10.1097/RCT.0b013e3182706562
Al Ansari N, Kim BS, Srirattanapong S, et al. (2014) Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? Abdom Imaging 39(6):1228–1240. doi:10.1007/s00261-014-0172-3
Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24(1):66–68
Nanashima A, Abo T, Murakami G, et al. (2013) Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 38(4):785–792. doi:10.1007/s00261-012-9974-3
Ariizumi S, Kotera Y, Takahashi Y, et al. (2011) Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 104(2):130–139. doi:10.1002/jso.21917
Galia M, Taibbi A, Marin D, et al. (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228. doi:10.5152/dir.2014.13184
Murakami T, Tsurusaki M (2014) Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. Liver Cancer 3(2):85–96. doi:10.1159/000343864
Nam SJ, Park KY, Yu JS, et al. (2012) Hepatic cavernous hemangiomas: relationship between speed of intratumoral enhancement during dynamic MRI and apparent diffusion coefficient on diffusion-weighted imaging. Korean J Radiol: Off J Korean Radiol Soc 13(6):728–735. doi:10.3348/kjr.2012.13.6.728
Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, et al. (2012) Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol 22(11):2514–2524. doi:10.1007/s00330-012-2519-x
Galea N, Cantisani V, Taouli B (2013) Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging 37(6):1260–1276. doi:10.1002/jmri.23947
Miller FH, Hammond N, Siddiqi AJ, et al. (2010) Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 32(1):138–147. doi:10.1002/jmri.22235
Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167(3):689–693. doi:10.1148/radiology.167.3.2834769
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adam, S.Z., Parthasarathy, S. & Miller, F.H. Intrahepatic cholangiocarcinomas mimicking other lesions. Abdom Imaging 40, 2345–2354 (2015). https://doi.org/10.1007/s00261-015-0480-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-015-0480-2